Genscript Biotech Corp Dividend
Why the stock moved Beta
Genscript Biotech Corp Dividend history 9 years
Dividend Analysis of the Genscript Biotech Corp Stock
| Current dividend yield | 4.26 % |
| Dividendenrendite 5 Jahre | 9.71 % |
| Dividend Yield 10Y | 9.65 % |
| Payout 3Y | 6.1 % |
When does Genscript Biotech Corp pay a dividend?
The Genscript Biotech Corp stock dividend is paid once a year. In order to receive a dividend, you should generally own the Genscript Biotech Corp stock before the ex-dividend date. The Dividend Calendar shows that the ex-day date was last at . The dividend from Genscript Biotech Corp was paid in June.
| Year | Dividend | Ex-day & Payday |
Frequency | |
|---|---|---|---|---|
| Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
| 2017 |
HK$0.012
HK$0.01
|
Jun 05 2017
Jun 05 2017
Jun 21 2017
Jun 05 17
Jun 21 17 |
Jun 21 2017 |
annual
yearly
|
How much dividend does Genscript Biotech Corp pay?
Genscript Biotech Corp paid a Dividend of HK$0.00 Per Share in the financial year 2025. With a stock price of HK$39.34 at Sep 18 2026, the current dividend yield is 0.00% (calculation: HK$0.00 / HK$39.34 = 0.00%). No special dividend was paid.
What is the Genscript Biotech Corp Dividend Yield and payout ratio?
The average Genscript Biotech Corp dividend yield over the last 5 years is 0.00% and the average over the last 10 years is 0.01%.
The payout ratio of Genscript Biotech Corp in relation to the last financial year is 0.00%. The payout ratio smoothed over 3 years is 0.00%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
| Metric | Genscript Biotech Corp |
|---|---|
| Current dividend yield | 0.00% |
| Dividend Yield 5Y | 0.00% |
| Dividend Yield 10Y | 0.01% |
| Payout 1Y | 0.00% |
| Payout 3Y | 0.00% |
Is the Genscript Biotech Corp dividend safe? Continuity & Dividend Growth
Is the Genscript Biotech Corp dividend safe?
Genscript Biotech Corp has been paying a dividend for 0 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
| Metric | Genscript Biotech Corp |
|---|---|
| Increased | 0 Years |
| Continuity | 0 Years |
| Paid | 0 Years |
Continuity
Genscript Biotech Corp has been paying a dividend for 0 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
Genscript Biotech Corp Stock Forecast 2026
On the stock exchange, the Genscript Biotech Corp stock (ISIN: KYG3825B1059) is not traded as a top scorer in September 2026 according to the dividend strategy.
The stock price of Genscript Biotech Corp 233.33% has risen since the beginning of the year 2026. However, the return generated in the past says nothing about the future return. You can find the Genscript Biotech Corp stock price in real time at the top of the page.
Genscript Biotech Corp (symbol: 1548) is valued at a Price / Earnings Ratio (P/E ratio) of -17.18 and a price/sales ratio (P/S ratio) of 12.74 valued. Based on analyst estimates, the Genscript Biotech Corp stock forecast 2026 of the current financial year corresponds to a valuation of 172.08 according to P/E ratio and 12.14 according to P/S.
| Metric | Genscript Biotech Corp |
|---|---|
| Dividend Score | ??/15 |
| Performance 2026 |
233.33%
|
| P/E TTM | -17.18 |
| P/S TTM | 12.74 |
| P/E forward | 172.08 |
| P/S forward | 12.14 |
Genscript Biotech Corp (symbol: 1548) is valued at a Price / Earnings Ratio (P/E ratio) of -17.18 and a price/sales ratio (P/S ratio) of 12.74 valued. Based on analyst estimates, the Genscript Biotech Corp stock forecast 2026 of the current financial year corresponds to a valuation of 172.08 according to P/E ratio and 12.14 according to P/S.
Discover more Dividend Stocks in Germany, USA and Worldwide
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
